Rabies Antiserum Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Rabies Antiserum Market size is expected to grow at an annual average CAGR of 6% during 2022-2028. The purpose of this guidance is to assist sponsors in developing a rabies virus monoclonal antibody (mAb) cocktail as an alternative to rabies virus immunoglobulin (RIG). Prevention of rabies when administered immediately after contact with rabies or potentially rabies animals. This draft guidance is intended to serve as a focal point for ongoing discussion among the Antiviral Agency, its sponsors, academia and the public. This guidance does not address the development of mAbs for rabies vaccines, rabies therapeutics, or other indications.

The following segmentation are covered in this report:

By Application

• Category II Exposure
• Category III Exposure

By Product

• 1500IU
• 1000IU
• 400IU
• Other

Company Profile

• Serum China
• Lanzhou Institute of Biological Products
• Wuhan Institute of Biological Products
• Premium Serums
• Haffkine Bio-Pharmaceutical
• Bharat Serums

Scope of the report

The research study analyses the Rabies Antiserum Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Rabies Antiserum Market Report

• What was the Rabies Antiserum Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Rabies Antiserum Market was the market leader in 2022?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.